Arbutus Biopharma News - ABUS

Company Name	Stock Ticker Symbol	Market	Type
Arbutus Biopharma Corporation	ABUS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.01	-0.37%	2.72	19:38:07

Open Price	Low Price	High Price	Close Price	Prev Close
2.71	2.65	2.81	2.72	2.73

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	07:30	GLOBE	Arbutus to Report First Quarter 2024 Financial Results and..
4/04/2024	08:30	GLOBE	Arbutus Biopharma Announces Claim Construction Ruling in its..
3/08/2024	07:30	GLOBE	Arbutus to Participate in Two Upcoming Investor Conferences
3/05/2024	16:48	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/2024	07:31	EDGAR2	Form 8-K - Current report
2/29/2024	07:30	GLOBE	Arbutus Reports Fourth Quarter and Year End 2023 Financial..
2/15/2024	07:30	GLOBE	Arbutus to Report Fourth Quarter and Year End 2023 Financial..
2/14/2024	16:38	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	10:48	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	19:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/05/2024	19:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	07:31	EDGAR2	Form 8-K - Current report
1/08/2024	07:30	GLOBE	Arbutus Announces 2024 Corporate Objectives and Provides..
1/04/2024	16:09	EDGAR2	Form 8-K - Current report
11/21/2023	08:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/09/2023	16:02	EDGAR2	Form 8-K - Current report
11/08/2023	07:30	GLOBE	Arbutus to Present at Jefferies London Healthcare Conference
11/07/2023	16:18	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:31	EDGAR2	Form 8-K - Current report
11/07/2023	07:30	GLOBE	Arbutus Reports Third Quarter 2023 Financial Results and..
11/07/2023	07:16	EDGAR2	Form 8-K - Current report
11/07/2023	07:15	GLOBE	Arbutus Announces CEO, William Collier, to Retire December..
10/24/2023	07:30	GLOBE	Arbutus to Report Third Quarter 2023 Financial Results and..
10/18/2023	07:30	GLOBE	Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B..
10/11/2023	08:06	EDGAR2	Form 8-K - Current report
10/11/2023	08:05	GLOBE	Arbutus Announces Multiple Abstracts Accepted for..
9/11/2023	17:07	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
9/11/2023	16:16	EDGAR2	Form 8-K - Current report
9/11/2023	16:15	GLOBE	Arbutus Announces Pipeline Updates and Dosing of the First..
9/07/2023	07:30	GLOBE	Arbutus to Participate in Two Upcoming Investor Conferences
8/03/2023	16:18	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/03/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	07:31	EDGAR2	Form 8-K - Current report
8/03/2023	07:30	GLOBE	Arbutus Reports Second Quarter 2023 Financial Results..
7/20/2023	07:30	GLOBE	Arbutus to Report Second Quarter 2023 Financial Results and..
7/13/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/13/2023	16:11	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
7/12/2023	16:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:48	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
7/12/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:10	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
7/12/2023	07:31	EDGAR2	Form 8-K - Current report
7/12/2023	07:30	GLOBE	Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of..
7/10/2023	16:02	EDGAR2	Form 8-K - Current report
7/10/2023	16:01	GLOBE	Arbutus Appoints Two New Executives
6/21/2023	07:30	GLOBE	Arbutus Doses First Patient in Additional Treatment Arm of..
6/21/2023	02:01	GLOBE	Arbutus Presents Preliminary AB-729 and Pegylated Interferon..
6/07/2023	02:01	GLOBE	Arbutus to Present AB-729 and AB-836 Data at EASL Congress..